Anticholinergics Tied to Physical Performance Decline in Older Adults
WEDNESDAY, July 16, 2025 -- Anticholinergics are associated with physical performance decline in older adults, according to a study published online July 10 in JAMA Network Open.
Shelly L. Gray, Pharm.D., from the University of Washington in Seattle, and colleagues assessed whether anticholinergic exposure is associated with accelerated physical performance decline in older adults. The analysis included 4,283 participants aged 65 years and older in the Adult Changes in Thought study at Kaiser Permanente Washington (February 1994 to March 2020).
The researchers found that compared with nonusers, there was a greater decline rate in gait speed among those with a 10-year total standardized daily dose (SDD) ≥1,096 (mean difference [MD] per year, −0.0132 m/s) and for two-year mean SDD ≥0.5 (MD per year, −0.0101 m/s). The lowest quasi-information criterion was seen for the four-year weighted cumulative exposures model, which showed a significantly greater decline rate per one-unit increase in weighted mean SDD (MD per year, −0.0034 m/s). For grip strength, there were no significant associations between conventional exposures, but the six-year weighted cumulative exposures model had the lowest quasi-information criterion (MD per year, −0.0329 kg).
"Anticholinergics are associated with numerous adverse outcomes in older adults; therefore, it is essential for clinicians to avoid their use when possible, prescribe the lowest effective dose, and periodically reevaluate patients to identify deprescribing opportunities to minimize potential harms," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Drop in Hospital Salaries, Staffing Reported After Private Equity Acquisitions
FRIDAY, Sept. 26, 2025 -- U.S. hospitals that undergo private equity acquisition may reduce salaries and staffing after acquisition, especially in emergency departments (EDs) and...
Poor Mental Health Outcomes More Likely With Hyperemesis Gravidarum
FRIDAY, Sept. 26, 2025 -- Hyperemesis gravidarum is associated with an increased risk for poorer mental health outcomes compared with pregnancy without hyperemesis gravidarum...
Personal Storytelling During Medical Training Aids Learning
THURSDAY, Sept. 25, 2025 -- A student-led program in which medical students share their own personal stories with illness during a preclinical curriculum enhances learning...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.